Patient Controlled Injectors Market Size, Share, Trends, Growth 2032

Patient Controlled Injectors Market Insights

According to Zion Market Research, the global Patient Controlled Injectors Market was worth USD 2.78 Billion in 2023. The market is forecast to reach USD 9.83 Billion by 2032, growing at a compound annual growth rate (CAGR) of 13.5% during the forecast period 2024-2032. The report offers a comprehensive analysis of the market, highlighting the factors that will determine growth, potential challenges, and opportunities that could emerge in the Patient Controlled Injectors Market industry over the next decade.

Request Free Sample

Patient Controlled Injectors Market: An Overview

Patient controlled injector is the breakthrough in injection administration. The medical device helps in fulfilling the unmet requirements of patients as it offers comfort and ease as compared to any other medical equipment. Moreover, the device is ergonomically created and helps in patient in improving self-care, thereby making it easier for the patients in effectively handling & administering the medicines at a prescribed period. Apart from this, the medical device is a subcutaneous drug delivery tool adhering to the patient body along with helping in inoculating huge volumes of medicine.

Patient Controlled Injectors Market: Growth Drivers

Escalating occurrence of chronic ailments such as autoimmune diseases, cancer, and blood ailments resulting in need for elongate duration of treatment will prompt the growth of patient controlled injectors industry over the assessment period. In addition to this, utility of patient controlled injectors has assisted in mitigating risks of contamination, needle stick injuries, and reducing medical errors caused as a result of parenteral mode of medicine administration through injection. This, in turn, will promulgate the expansion of patient controlled injectors industry over the upcoming years.

Request Free Sample

Breakthroughs in pharma sector resulting in launching of new drug therapies for treating severe disorders will translate into massive demand for patient controlled injectors across the healthcare industry over 2020-2026. Apparently, patient controlled injector provides efficient target drug delivery along with long-term medicine residence to affected regions of heart systems, thereby enhancing the popularity of the product in the recent years.

Patient Controlled Injectors Market: Report Scope

North America To Make Notable Contributions Towards Overall Market Share By 2032

The regional market growth over 2020-2026 is due to surge in the chronic ailment occurrence requiring patient controlled injectors for inoculating medicines. In addition to this, presence of major participants profiled in the study will drive the regional market trends.

Some of the leading players in the global market inlcude

• Gerresheimer AG
• scPharmaceuticals Inc.
• United Therapeutics Corporation
• Westbourne Medical Limited
• Enable Injections
• Johnson and Johnson Services Inc.
• F. Hoffmann-La Roche Ltd.
• BD
• Ypsomed AG.

The global Patient Controlled Injectors Market is segmented as follows:

By Application:

• Cancer Treatment
• Auto-immune Treatment
• Blood Disorders Treatment

By Product:

• Electronic Wearable Injectors
• Mechanical Wearable Injectors
• Infusion Pumps

By Distribution Channel:

• Hospital Pharmacies
• Retail Pharmacies
• Mail Order Pharmacies

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa